Learning Objectives:
1. Understand the pre-clinical data suggesting metformin's role as a cancer treatment.
2. Identify the limitations of the current data indicating metformin might be used for cancer.
3. Outline the additional evidence required before implementation into clinical care.
Session date:
12/11/2017 - 5:00pm to 6:00pm CST
Location:
UCMC
M-170
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Iris Romero, M.D., M.S.